Novavax Inc (NVAX): Mater Research initiates combined Covid-...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	17
Posts	2092
Boards Moderated	1
Alias Born	09/27/2020

JoeForkeyBolo

Re: None

Monday, 10/14/2024 9:18:33 AM

Monday, October 14, 2024 9:18:33 AM

Mater Research initiates combined Covid-flu vaccine trial

October 14, 2024

Mater Research in Brisbane, Australia, has commenced a clinical trial for a new combined Covid-19 and flu vaccine from Novavax aimed at providing protection for individuals who are unable to receive mRNA vaccines.

This non-mRNA vaccine is protein-based and includes a segment of the coronavirus spike protein.

It is designed to trigger an immune response by introducing a harmless piece of the coronavirus spike protein to the immune system.

As the immune cells recognise the spike protein as a foreign invader, they start to build a defence against it.

Eligible volunteers will include healthy individuals over the age of 65 years who have not received an influenza vaccine in the past two months.

The trial is set to commence on 4 November and will span a three-week period.

https://www.clinicaltrialsarena.com/news/mater-research-initiates-combined-covid-flu-vaccine-trial/